China Universal Asset Management »

Neumora Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $52k 28k 1.82
2025-06-30 $24k 33k 0.73
2025-03-31 $32k 32k 1.00
2024-12-31 $363k 34k 10.60

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Neumora Therapeutics

Softbank Group Corp
MIC Capital Management UK
Siren
Vanguard Group
FMR
Wellcome Trust Limited, as Trustee of the Wellcome Trust
ICONIQ Capital
Lunate Capital
Millennium Management
T. Rowe Price Investment Management
Johnson & Johnson
BlackRock
Tang Capital Management
Renaissance Technologies
Two Sigma Advisers

View all funds holding Neumora Therapeutics